Granules India DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.75×	0.76×	0.76×	0.74×	0.75×
	0.91×	0.88×	0.92×	0.84×	0.94×
	17.2%	16.6%	16.1%	14.4%	16.2%
	0.77×	0.77×	0.76×	0.86×	0.96×
	1.52×	1.52×	1.68×	1.71×	1.73×
	13.7%	13.0%	14.3%	13.2%	19.0%
	13.5%	13.5%	14.5%	14.1%	19.1%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

GRANULES₹796.60

Granules India Ltd.

· Pharma & Health

₹ CrorePeersAUROPHARMA IPCALAB AARTIDRUGS ERIS INDGN EMCURE JUBLPHARMA CONCORDBIOMcap ₹19,740 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.75	0.74	0.76	0.76	0.75
Interest Burden (Pretax/EBIT) ×	0.94	0.84	0.92	0.88	0.91
EBIT Margin %	16.16	14.39	16.06	16.57	17.23
Asset Turnover ×	0.96	0.86	0.76	0.77	0.77
Financial Leverage (Assets/Equity) ×	1.73	1.71	1.68	1.52	1.52
ROE (5-step product, year-end total equity) %	19.02	13.24	14.31	12.96	13.75
ROE (owners' profit / average owners' equity) %	19.06	14.05	14.45	13.52	13.52

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.